HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beihua Kong Selected Research

PDZ-binding kinase

1/2021PBK promotes aggressive phenotypes of cervical cancer through ERK/c-Myc signaling pathway.
1/2019PBK, targeted by EVI1, promotes metastasis and confers cisplatin resistance through inducing autophagy in high-grade serous ovarian carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Beihua Kong Research Topics

Disease

79Neoplasms (Cancer)
06/2022 - 09/2002
77Ovarian Neoplasms (Ovarian Cancer)
12/2022 - 11/2005
17Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2021 - 01/2011
15Carcinoma (Carcinomatosis)
12/2021 - 07/2002
13Ovarian Epithelial Carcinoma
01/2022 - 07/2002
12Endometrial Neoplasms (Endometrial Cancer)
06/2021 - 08/2009
12Carcinogenesis
01/2021 - 12/2010
10Neoplasm Metastasis (Metastasis)
01/2021 - 01/2010
7Breast Neoplasms (Breast Cancer)
12/2021 - 08/2009
5Leiomyoma (Uterine Fibroids)
09/2018 - 01/2011
4Disease Progression
12/2022 - 01/2021
3Infections
01/2021 - 10/2011
3Lymphatic Metastasis
01/2021 - 01/2012
3Endometriosis
01/2019 - 08/2013
3Necrosis
06/2015 - 11/2005
2Nausea
12/2022 - 01/2021
2Bites and Stings (Sting)
01/2022 - 10/2021
2Thrombocytopenia (Thrombopenia)
05/2021 - 04/2012
2Inflammation (Inflammations)
12/2019 - 10/2011
2Ascites
11/2019 - 08/2013
2Smooth Muscle Tumor
09/2018 - 01/2018
2Ectopic Pregnancy
09/2017 - 10/2013
2Primary Ovarian Insufficiency
01/2017 - 04/2014
2Adenomyosis
04/2016 - 01/2013
2Missed Abortion
01/2013 - 05/2011
1Anemia
12/2022
1Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational)
04/2022

Drug/Important Bio-Agent (IBA)

24Proteins (Proteins, Gene)FDA Link
12/2021 - 09/2002
15Biomarkers (Surrogate Marker)IBA
12/2021 - 07/2006
13Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2017
10PlatinumIBA
12/2022 - 10/2017
10Biological ProductsIBA
06/2022 - 07/2007
9MicroRNAs (MicroRNA)IBA
01/2019 - 04/2011
8Poly(ADP-ribose) Polymerase InhibitorsIBA
03/2022 - 10/2017
8Messenger RNA (mRNA)IBA
01/2021 - 07/2007
6Transcription Factors (Transcription Factor)IBA
01/2021 - 12/2010
6Pharmaceutical PreparationsIBA
10/2020 - 07/2002
5olaparibIBA
12/2022 - 01/2020
51-phenyl-3,3-dimethyltriazene (PDT)IBA
06/2018 - 11/2005
4RNA Splicing FactorsIBA
01/2022 - 01/2017
4ORALIT (ORS)IBA
01/2020 - 06/2011
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020 - 09/2009
4Photosensitizing Agents (Photosensitizers)IBA
06/2018 - 11/2005
4DNA (Deoxyribonucleic Acid)IBA
11/2015 - 04/2010
4hematoporphyrin monomethyl etherIBA
10/2011 - 11/2005
3RNA (Ribonucleic Acid)IBA
06/2022 - 12/2017
3Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
03/2022 - 01/2021
3CytokinesIBA
10/2021 - 03/2013
3Conditioned Culture MediaIBA
01/2019 - 09/2009
3Estrogen ReceptorsIBA
01/2019 - 03/2012
3CateninsIBA
01/2019 - 11/2015
3Interleukin-10 (Interleukin 10)IBA
10/2018 - 03/2013
3hypocrellin BIBA
06/2018 - 10/2011
3Cadherins (E-Cadherin)IBA
02/2016 - 05/2013
3GoldIBA
07/2014 - 07/2011
26-methyladenineIBA
01/2022 - 11/2017
2Hormones (Hormone)IBA
06/2021 - 09/2016
2VaccinesIBA
01/2021 - 11/2013
2Oncogene Proteins (Oncogene Protein)IBA
01/2021 - 03/2013
2PDZ-binding kinaseIBA
01/2021 - 01/2019
2ChromatinIBA
01/2021 - 01/2016
2Glycoproteins (Glycoprotein)IBA
11/2020 - 03/2013
2kallistatinIBA
01/2020 - 12/2019
2LigandsIBA
01/2019 - 10/2018
2Fumarate Hydratase (Fumarase)IBA
09/2018 - 01/2016
2Levonorgestrel (Plan B)FDA LinkGeneric
08/2017 - 01/2013
2Paclitaxel (Taxol)FDA LinkGeneric
01/2017 - 04/2012
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2016 - 01/2013
2Fatty Acids (Saturated Fatty Acids)IBA
12/2014 - 06/2012
2Glucose (Dextrose)FDA LinkGeneric
07/2014 - 07/2011
2Calbindin 2IBA
08/2013 - 11/2011
2Radiation-Sensitizing AgentsIBA
02/2013 - 09/2012
2Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2012 - 01/2010
2Transforming Growth Factor beta1 (TGF beta 1)IBA
09/2009 - 09/2009
2Ganciclovir (Cytovene)FDA LinkGeneric
03/2003 - 09/2002
1Poly Adenosine Diphosphate RiboseIBA
12/2022
1RNA-Binding Proteins (RNA-Binding Protein)IBA
06/2022
1Dactinomycin (Actinomycin)FDA LinkGeneric
04/2022
1Methotrexate (Mexate)FDA LinkGeneric
04/2022
1I-antigenIBA
01/2022
1adavosertibIBA
01/2022
1Antiviral Agents (Antivirals)IBA
01/2022
1N-methyladenosineIBA
01/2022

Therapy/Procedure

28Therapeutics
06/2022 - 09/2002
10Drug Therapy (Chemotherapy)
04/2022 - 04/2014
7Radiotherapy
01/2019 - 01/2011
6Lymph Node Excision (Lymph Node Dissection)
07/2022 - 02/2012
5Immunotherapy
10/2021 - 04/2010
5Photochemotherapy (Photodynamic Therapy)
06/2018 - 11/2005
3Aftercare (After-Treatment)
01/2022 - 05/2010
3Neoadjuvant Therapy
01/2021 - 08/2013
3Length of Stay
01/2021 - 01/2011
3Lasers (Laser)
12/2014 - 07/2006
2Cytoreduction Surgical Procedures
01/2022 - 09/2015
2Cesarean Section (Caesarean Section)
12/2018 - 02/2013
2Laparotomy
09/2017 - 03/2012
2Hysterectomy
04/2016 - 06/2015
2Intraperitoneal Injections
07/2014 - 03/2003
2Induced Abortion (Induced Abortions)
02/2013 - 01/2013
2Molecular Targeted Therapy
07/2010 - 09/2009